Nitrosoureas: important new drugs for the treatment of cancer
Salmon, S.E.
Arizona Medicine 33(2): 102-104
1976
ISSN/ISBN: 0004-1556 PMID: 1275737 Document Number: 106359
Document emailed within 1 workday
Related Documents
Mitchell, E.P.; Schein, P.S. 1986: Contributions of nitrosoureas to cancer treatment Cancer Treatment Reports 70(1): 31-41Wolf, J. 1976: Nitrosoureas as single agents in the treatment of pulmonary cancer Cancer Treatment Reports 60(6): 753-756
Bergh, J. 2015: Sweden does not prioritize important cancer drugs Lakartidningen 112
Hansch, C.; Smith, N.; Engle, R.; Wood, H. 1972: Quantitative structure-activity relationships of antineoplastic drugs: nitrosoureas and triazenoimidazoles Cancer ChemoTherapy Reports 56(4): 443-456
Fürst, R.; Vollmar, A.M. 2013: A new perspective on old drugs: non-mitotic actions of tubulin-binding drugs play a major role in cancer treatment Die Pharmazie 68(7): 478-483
Vanhaelen, M.H. 1992: Taxol and related diterpenoids of Taxus sp.: important acquisitions in the treatment of cancer Journal de Pharmacie de Belgique 47(5): 417-424
Omura, G.A.; Shingleton, H.M.; Creasman, W.T.; Blessing, J.A.; Boronow, R.C. 1978: Chemotherapy of gynecologic cancer with nitrosoureas: a randomized trial of CCNU and methyl-CCNU in cancers of the cervix, corpus, vagina, and vulva Cancer Treatment Reports 62(5): 833-835
Davis, L.E. 1979: Important interactions of antibiotic drugs Journal of the American Veterinary Medical Association 175(7): 729-730
Saksela, E. 2004: New drugs for cancer treatment Duodecim; Laaketieteellinen Aikakauskirja 120(10): 1185-1187
Pollock, K.; Grime, J. 2000: Patients' views on cost effectiveness of drugs are important Bmj 321(7271): 1292
Kataoka, H.; Jho, T.; Itoh, M. 2005: Recent topics on important drugs for H. pylori eradication: Omeprazole Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl. 11: 333-337
Solberg, C.O. 1983: Anaerobic infections--the most important antimicrobial drugs and their clinical profile Scandinavian Journal of Gastroenterology. Suppl 85: 14-22
Harboe, K.; Todnem, K.; Zotova, L.; Lind, A.; Ogreid, D. 2000: New drugs in the treatment of advanced colorectal cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(23): 2777-2780
Okazaki, K.; Mori, S.; Tahashi, K. 2005: Recent topics on important drugs for H. pylori eradication: Pantoprazole sodium Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl. 11: 354-360
Namazi, M.R. 2004: Prescribing antidepressant drugs for pemphigus patients: An important point to keep in mind Dermatology Online Journal 10(1): 22
Nishino, T. 2005: Recent topics on important drugs for H. pylori eradication: Minocycline (MINO) Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl. 11: 382-386
Kalland, T. 2005: Antibody-based cancer drugs: developing antibody therapeutic approaches to deliver individualized cancer drugs Idrugs: the Investigational Drugs Journal 8(5): 364-365
Khodakov, M.B. 1973: International pharmacopeia, an important document for the organization of internal government control of drugs Farmatsevtychnyi Zhurnal 28(5): 77-79
Lechat, P. 1974: Periodical re-evaluation of the undesirable side effects of old drugs. An important mission of drug surveillance La Nouvelle Presse Medicale 3(24): 1571-1573
Turrisi, A.T. 2002: The new drugs and biologics as sensitizers in the treatment of non-small cell lung cancer I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 1(4): S55-S57